See the innovative ideas that help transform healthcare, and how Janssen research and development hopes to make further advancements in medicine.
Research & Development. Creativity & Fresh Ideas. Science & Solutions. Collaboration is in our DNA. We know... Partner with Us We are committed to partnering with those whose innovative thinking will bring new and creative solutions to the field of medicine. ...
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and one of the world’s leaders in oncology, is focused on harnessing the most compelling science with the aim of intercepting, preventing, treating, and ultimately curing cancer. Working toward t...
Eli Lilly & CompanyGarry NeilJanssen Research and Development
今天,生物制药公司Janssen Research & Development宣布,美国FDA已授予其在研抗抑郁新药esketamine突破性疗法认定,适用于有自杀倾向的重度抑郁症(Major depression disorder)。如果最终获得FDA批准,esketamine将是近50年来治疗重度抑郁症的第一个新药。 抑郁症是一种在全世界范围内常见的精神疾患,估计共有3.5亿名患者,遍布...
(Janssen Research & Development, LLC) Talquetamab是一款first-in-class现货型双特异性T细胞结合抗体,能同时靶向MM细胞上的GPRC5D和T细胞上的CD3,是继BCMA的Tecvayli之后,第二个用于多发性骨髓瘤的双特异性抗体。于2023年 8 月获 FDA 加速批准上市,其获批基于一项 I/II 期 MonumenTAL-1 临床试验的结果。结果...
JYSB1800260 人源抗CD38单克隆抗体(Daratumumab)注射液 治疗用生物制品 补充申请 2018-12-05 Janssen Research & Development, LLC 已发件 2019-02-18 补充申请 查看 查看 JXHL1900057 Niraparib胶囊 化药2.4 进口 2019-03-18 Janssen Research & Development, LLC 在审评审批中(在药审中心) 2019-...
janssenresearchdevelopmentllcendocrinologic464646 系统标签: endocrinologicjanssenllccanagliflozindevelopmentresearch 1Approved,Date:11December2012JanssenResearch&Development,LLCEndocrinologicandMetabolicDrugsAdvisoryCommitteeJanuary10,2013CanagliflozinasanAdjunctiveTreatmenttoDietandExerciseAloneorCo-administeredwithOtherAntihypergly...
Janssen Research & Development. “By advancing science in these areas, our new research platforms will strive to deliver the next generation of transformational medical innovation. We believe the positive impact on people, communities, governments, medicine and the global economy will be dramatic and ...
patients with PAD who have recently undergone a revascularization procedure, the VOYAGER PAD study results reinforce the benefits of Xarelto in patients with PAD,” said Dr Joerg Moeller, member of the Executive Committee at Bayer AG’s Pharmaceuticals Division and Head of Research and Development. ...